It’s getting bad out there, folks.
Word on the street is tensions are rising on Facebook.
Friends and relatives unfriending each other in fits of public rage is quickly becoming a go-to post-election puff piece for lazy reporters.
“As the results rolled in and Donald Trump’s election as the 45th president of the United States became official, supporters of both candidates took to Facebook to express their joy and dismay at the outcome,” the Chicago Tribune reports. “For some, the reaction from supporters of both candidates felt like a bit much.”
Remember kids, Thanksgiving is only two weeks away. That means you have a big decision to make…
You can get political at Grandma’s house and alienate your entire family before sitting down for the big meal…
Or you can drop some knowledge at the table and show your second cousin why the heck the stock market is plowing higher on the heels of Trump’s big win.
Investors were blindsided by Trump on Tuesday. But the big story of the election so far is the resilience of the stock market.
Futures collapsed overnight at the prospect of madman Trump with his finger on the button. By Wednesday morning, most of the damage had been repaired. And by the close, the S&P 500 had gained more than 1%.
This morning, the Dow Jones Industrial Average is just 47 points from setting a new all-time high. The idea that the market would quickly crumble after a Trump victory is dead.
Meanwhile, new trades are beginning to emerge.
With Hillary’s rhetoric out of the way, the biotech sector is getting a second wind. All that talk about price gouging that helped crush the summer rally is out to pasture.
We’ve been watching biotech get run into the ground with punch after punch from the politicial trash talk. It was a little less than a year ago that Hillary really put the pressure on the industry. Now that she’s finally out of the picture, things are finally looking up for the sector.
“Naturally, fresh off the heels of a Trump win/Hillary loss, investors started snatching up shares in the biotech sector left and right,” our biotech expert Ray Blanco explains. “The Nasdaq Biotech Index was up 5% when markets opened yesterday.”
The SPDR S&P Biotech ETF (NYSE:XBI) finished the day up more than 10%. These stocks had been in free-fall since early October. Now they’re jumping the line and setting up for another breakout…
Conventional wisdom says that regulation of the pharma industry is going to be almost nonexistent under a Trump presidency. Of course, we have no idea whether this is true or not. But these are the emotions that are persuading speculators to pile back into biotech.
Unexpected rallies like we’re seeing this week are violent. They totally upend the sentiment picture and cause a lot of irrational behavior. Usually, these big rallies and short squeezes last a lot longer than most folks expect, giving us a great opportunity to pull in huge gains in over a very short timeframe.
Don’t get left behind…
This story originally appeared in the Daily Reckoning